0,944  0,003  CYP1A2 substrate
0,935  0,003  Amyloid beta aggregation inhibitor
0,931  0,003  Chemoprotective
0,929  0,003  Antioxidant
0,900  0,001  SULT1A3 substrate
0,899  0,001  Creatine kinase inhibitor
0,897  0,003  UGT1A6 substrate
0,885  0,002  Antimutagenic
0,876  0,003  Free radical scavenger
0,865  0,003  UGT1A9 substrate
0,858  0,004  UDP-glucuronosyltransferase substrate
0,847  0,003  Genotoxic
0,828  0,003  Skin whitener
0,825  0,003  Sulfotransferase substrate
0,826  0,005  Antihypercholesterolemic
0,823  0,004  CYP2C19 substrate
0,826  0,008  Caspase 9 stimulant
0,821  0,005  Antidiabetic
0,821  0,005  Cyclophilin D inhibitor
0,816  0,003  Antihypertriglyceridemic
0,822  0,014  Apoptosis agonist
0,802  0,004  NOS2 expression inhibitor
0,803  0,007  CYP2C9 substrate
0,807  0,012  Transcription factor NF kappa B inhibitor
0,797  0,004  AR expression inhibitor
0,807  0,014  Antiinflammatory
0,793  0,002  Melanin inhibitor
0,790  0,004  Hepatic disorders treatment
0,790  0,004  Aldehyde oxidase inhibitor
0,789  0,004  CTGF expression inhibitor
0,789  0,005  Cytostatic
0,787  0,003  UGT1A3 substrate
0,782  0,005  Mutagenic
0,779  0,003  UGT1A1 substrate
0,779  0,003  Monophenol monooxygenase inhibitor
0,766  0,007  Chemopreventive
0,760  0,003  Hepatoprotectant
0,765  0,023  Alpha-glucosidase inhibitor
0,745  0,004  Hypoglycemic
0,747  0,011  TNF expression inhibitor
0,736  0,002  Cystathionine beta-synthase inhibitor
0,739  0,005  Caspase 3 stimulant
0,734  0,002  Carbonic anhydrase III inhibitor
0,726  0,008  Prostate cancer treatment
0,717  0,005  Cardioprotectant
0,717  0,004  Histamine release inhibitor
0,715  0,007  CYP2D6 substrate
0,723  0,016  CYP3A4 substrate
0,709  0,012  15-Lipoxygenase inhibitor
0,701  0,005  CYP2C19 inhibitor
0,699  0,004  Apoptosis antagonist
0,691  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,690  0,006  Antiosteoporotic
0,676  0,003  Carbonic anhydrase VI inhibitor
0,664  0,002  UGT2B15 substrate
0,668  0,007  NOS3 expression inhibitor
0,654  0,005  Antiamyloidogenic
0,658  0,010  Bone diseases treatment
0,647  0,002  Carbonic anhydrase XV inhibitor
0,647  0,016  Alzheimer's disease treatment
0,623  0,004  NOS3 expression enhancer
0,622  0,005  GABA C receptor rho-3 antagonist
0,620  0,004  UGT2B1 substrate
0,610  0,005  Antineoplastic (osteosarcoma)
0,610  0,010  CYP2C9 inhibitor
0,598  0,002  Histidine decarboxylase inhibitor
0,596  0,001  Papain-like protease (SARS coronavirus) inhibitor
0,605  0,011  Proliferative diseases treatment
0,591  0,004  Lipid peroxidase inhibitor
0,591  0,005  Peroxidase inhibitor
0,594  0,008  Tumour necrosis factor alpha release inhibitor
0,589  0,004  Amylase inhibitor
0,579  0,003  Antihemorrhagic
0,581  0,009  Antipyretic
0,573  0,003  Xanthine oxidase inhibitor
0,574  0,011  Nitric oxide antagonist
0,545  0,011  DNA damaging
0,573  0,040  Antineoplastic (breast cancer)
0,540  0,009  Antineoplastic enhancer
0,548  0,019  Sensitization
0,529  0,004  Estrogen receptor beta antagonist
0,526  0,004  GST M1-1 substrate
0,545  0,032  GST A substrate
0,538  0,031  Antibacterial
0,516  0,009  Antihypoxic
0,511  0,004  Estrogen antagonist
0,494  0,004  Gout treatment
0,491  0,004  Antitussive
0,501  0,019  Lipoxygenase inhibitor
0,503  0,023  Carcinogenic
0,508  0,031  Teratogen
0,482  0,006  Antihypotensive
0,478  0,005  Antialcoholic
0,473  0,003  Carbonic anhydrase XIII inhibitor
0,474  0,005  Antidote
0,497  0,040  Antileukemic
0,460  0,005  Glutathione S-transferase substrate
0,469  0,016  UGT2B4 substrate
0,451  0,007  5 Hydroxytryptamine uptake stimulant
0,462  0,020  Antidiabetic (type 2)
0,450  0,011  UGT1A4 substrate
0,463  0,027  Antineoplastic (cervical cancer)
0,449  0,016  Vascular (periferal) disease treatment
0,454  0,022  ICAM1 expression inhibitor
0,460  0,035  Embryotoxic
0,427  0,005  Acetylcholinesterase inhibitor
0,418  0,004  Estrogen agonist
0,413  0,004  Cholesterol synthesis inhibitor
0,438  0,030  Antineoplastic (brain cancer)
0,451  0,049  Antipruritic, allergic
0,445  0,054  5 Hydroxytryptamine release inhibitor
0,425  0,033  Radioprotector
0,405  0,016  P-glycoprotein inhibitor
0,391  0,003  Estrogen receptor beta agonist
0,398  0,011  Antiviral (Influenza)
0,394  0,009  Pneumotoxic
0,388  0,004  Nitric-oxide synthase stimulant
0,393  0,012  UGT2B7 substrate
0,391  0,010  VCAM1 expression inhibitor
0,402  0,024  Antidiabetic symptomatic
0,412  0,034  Antineoplastic (glioma)
0,411  0,036  Antineoplastic (pancreatic cancer)
0,425  0,054  Atherosclerosis treatment
0,375  0,008  Diabetic nephropathy treatment
0,375  0,009  Antiviral (Influenza A)
0,400  0,035  Vasodilator, coronary
0,400  0,039  Lipoprotein disorders treatment
0,366  0,004  Estrogen receptor alpha antagonist
0,365  0,005  Interleukin 4 antagonist
0,368  0,010  Protein-tyrosine phosphatase inhibitor
0,391  0,034  CYP3A4 inhibitor
0,367  0,010  Liver fibrosis treatment
0,372  0,020  Antineoplastic (sarcoma)
0,357  0,007  Protein-tyrosine phosphatase 1B inhibitor
0,402  0,053  Angiogenesis inhibitor
0,370  0,021  RNA-directed DNA polymerase inhibitor
0,356  0,012  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,346  0,002  Antiviral (Hepatitis A)
0,347  0,005  Beta glucuronidase inhibitor
0,378  0,039  Cytotoxic
0,341  0,003  Antiviral (SARS coronavirus)
0,341  0,003  Antiviral (Coronavirus)
0,358  0,021  Antihelmintic
0,349  0,013  Topoisomerase II inhibitor
0,365  0,030  Antiparasitic
0,347  0,014  Cholinergic
0,398  0,065  Antineoplastic (lung cancer)
0,378  0,050  5 Hydroxytryptamine release stimulant
0,389  0,064  Ulceration
0,370  0,047  Antineoplastic (melanoma)
0,354  0,032  Vasodilator
0,374  0,053  Antifungal
0,333  0,011  Neurotrophic factor enhancer
0,332  0,012  Antihelmintic (Nematodes)
0,328  0,009  NADPH oxidase inhibitor
0,324  0,009  DNA polymerase I inhibitor
0,317  0,004  VEGF expression inhibitor
0,369  0,059  Immunostimulant
0,347  0,037  Antineoplastic (glioblastoma multiforme)
0,315  0,005  HDL-cholesterol increasing
0,314  0,004  SULT1A1 substrate
0,369  0,060  Antineoplastic (colorectal cancer)
0,331  0,024  Platelet adhesion inhibitor
0,341  0,035  Angiogenesis stimulant
0,316  0,011  M18 aspartyl aminopeptidase inhibitor
0,308  0,004  Gastritis treatment
0,354  0,051  Spasmolytic
0,310  0,009  UGT2B9 substrate
0,303  0,004  NAD(P)H dehydrogenase (quinone) inhibitor
0,353  0,056  Antineoplastic (ovarian cancer)
0,368  0,077  Immunosuppressant
0,294  0,005  Postmenopausal disorders treatment
0,335  0,047  CYP1A2 inhibitor
0,342  0,054  Analeptic
0,292  0,005  Alcohol dehydrogenase inhibitor
0,289  0,003  Xanthine dehydrogenase inhibitor
0,347  0,062  Antineoplastic (colon cancer)
0,290  0,008  Topoisomerase II alpha inhibitor
0,321  0,043  Hypolipemic
0,338  0,060  Respiratory analeptic
0,286  0,010  LDLR expression enhancer
0,331  0,058  Metabolic disease treatment
0,290  0,018  Protein kinase stimulant
0,276  0,004  Carbonic anhydrase VII inhibitor
0,273  0,003  Paget's disease treatment
0,333  0,064  12-Lipoxygenase inhibitor
0,270  0,003  SULT1E1 substrate
0,269  0,004  Estrogen receptor alpha agonist
0,283  0,020  Insulin sensitizer
0,274  0,014  Alkylator
0,267  0,008  Cyclooxygenase 3 inhibitor
0,305  0,049  Antineoplastic (liver cancer)
0,260  0,006  AMP-activated protein kinase stimulant
0,254  0,005  Antineoplastic (uterine cancer)
0,259  0,013  UDP-glucose 4-epimerase inhibitor
0,333  0,086  Stroke treatment
0,250  0,006  CF transmembrane conductance regulator agonist
0,258  0,016  Antiprotozoal (Coccidial)
0,256  0,017  Aldehyde dehydrogenase inhibitor
0,259  0,021  Hemostatic
0,252  0,014  Butyrylcholinesterase inhibitor
0,241  0,004  Carbonic anhydrase VB inhibitor
0,253  0,017  Antifungal enhancer
0,243  0,007  Aromatase inhibitor
0,239  0,003  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,240  0,005  Carbonic anhydrase V inhibitor
0,307  0,072  Antiischemic
0,289  0,055  Superoxide dismutase inhibitor
0,275  0,041  Abortion inducer
0,261  0,029  Antiviral (Hepatitis)
0,262  0,031  Antipruritic, non-allergic
0,243  0,013  GABA C receptor rho-2 antagonist
0,235  0,005  Aldose reductase inhibitor
0,310  0,081  FMO1 substrate
0,254  0,027  Carcinogenic, group 3
0,277  0,063  Antineoplastic (renal cancer)
0,256  0,044  DNA methyltransferase I inhibitor
0,228  0,017  Antineoplastic antibiotic
0,223  0,012  Constipation treatment
0,222  0,012  Breast cancer-resistant protein inhibitor
0,214  0,004  Carbonic anhydrase VA inhibitor
0,218  0,008  HIV-1 integrase (3'-Processing) inhibitor
0,225  0,017  Antirickettsial
0,216  0,010  Mucolytic
0,214  0,008  Antiviral (Influenza B)
0,222  0,016  Expectorant
0,209  0,005  DOPA decarboxylase inhibitor
0,205  0,004  Fatty acid synthase inhibitor
0,224  0,024  GST P1-1 substrate
0,229  0,031  Succinate dehydrogenase inhibitor
0,223  0,026  Alkaline phosphatase inhibitor
0,262  0,067  Cardiovascular analeptic
0,295  0,099  Vasodilator, peripheral
0,205  0,009  HIV-1 integrase (Strand Transfer) inhibitor
0,224  0,030  Antiviral (Hepatitis C)
0,250  0,059  Antiulcerative
0,287  0,097  Antithrombotic
0,258  0,069  Antiprotozoal (Leishmania)
0,194  0,010  Actinic keratosis treatment
0,281  0,097  Sodium/bile acid cotransporter inhibitor
0,196  0,014  Uric acid excretion stimulant
0,194  0,012  Multidrug resistance-associated protein 1 inhibitor
0,210  0,030  UGT2B10 substrate
0,216  0,036  Interferon gamma antagonist
0,205  0,025  Topoisomerase I inhibitor
0,235  0,057  DNA methylase inhibitor
0,244  0,066  Cyclic AMP phosphodiesterase inhibitor
0,195  0,018  Antihelmintic (Trematoda)
0,207  0,032  Alpha-N-acetylglucosaminidase inhibitor
0,208  0,037  Toxic, respiratory center
0,244  0,074  Tyrosine 3 hydroxylase inhibitor
0,201  0,032  Arachidonic acid antagonist
0,177  0,014  Protein kinase C zeta inhibitor
0,241  0,080  Myocardial infarction treatment
0,224  0,068  Psychostimulant
0,213  0,058  CYP2B6 inhibitor
0,193  0,039  Carcinogenic, group 1
0,172  0,020  GABA C receptor antagonist
0,252  0,100  FMO3 substrate
0,235  0,085  Antineoplastic (non-small cell lung cancer)
0,178  0,029  Chelator
0,251  0,103  CYP2D6 inhibitor
0,175  0,027  Microtubule formation inhibitor
0,173  0,027  Liver cirrhosis treatment
0,173  0,029  Carcinogenic, group 2B
0,190  0,048  Phospholipase A2 inhibitor
0,219  0,077  Peptidyltransferase inhibitor
0,162  0,020  Ca2+-transporting ATPase inhibitor
0,150  0,010  Lipase inhibitor
0,157  0,017  Electron transport complex I inhibitor
0,171  0,034  Adenylate cyclase stimulant
0,184  0,046  MAO inhibitor
0,182  0,045  Antidiarrheal
0,157  0,021  Androgen antagonist
0,154  0,019  Toll-Like receptor 4 antagonist
0,150  0,015  UGT2B11 substrate
0,150  0,015  Macrophage migration inhibitory factor inhibitor
0,167  0,032  5-Lipoxygenase inhibitor
0,187  0,053  Antiviral (Herpes)
0,153  0,020  GABA C receptor rho-1 antagonist
0,195  0,063  Diabetic retinopathy treatment
0,160  0,028  Heat shock protein 70 antagonist
0,197  0,066  Antiviral (Ebola)
0,180  0,049  Antineoplastic (squamous cell carcinoma)
0,174  0,046  Mannose-6-phosphate isomerase inhibitor
0,177  0,050  Insulin secretagoues
0,139  0,011  Alcohol oxidase inhibitor
0,155  0,028  Photosensitizer
0,150  0,023  Urease inhibitor
0,213  0,089  MAP-kinase-activated kinase 5 inhibitor
0,144  0,021  Anabolic
0,138  0,017  Keratolytic
0,130  0,010  SULT1A2 substrate
0,217  0,098  DNA synthesis inhibitor
0,171  0,055  Heat shock protein 90 antagonist
0,136  0,022  NADH dehydrogenase inhibitor
0,251  0,138  Antineoplastic (small cell lung cancer)
0,164  0,052  Pancreatic disorders treatment
0,227  0,115  Antineoplastic (multiple myeloma)
0,114  0,004  Postcoital contraceptive
0,140  0,031  Gastric antisecretory
0,222  0,114  Radiosensitizer
0,135  0,028  Carcinogenic, group 2A
0,177  0,070  Tumour necrosis factor antagonist
0,119  0,013  Narcotic antagonist
0,156  0,051  Antiseptic
0,119  0,014  D-Ala-D-Ala ligase inhibitor
0,110  0,005  Transcription factor RelA inhibitor
0,138  0,034  Mediator release inhibitor
0,169  0,065  Eye irritation, high
0,235  0,135  Prostaglandin dehydrogenase inhibitor
0,197  0,096  Antineoplastic (lymphoma)
0,175  0,074  Antineoplastic (gastric cancer)
0,164  0,064  Acaricide
0,141  0,041  Contraceptive female
0,150  0,050  Antiprotozoal (Trichomonas)
0,102  0,003  Sodium/glucose cotransporter 2 inhibitor
0,123  0,024  Ornithine decarboxylase inhibitor
0,108  0,010  Estradiol 17 beta-dehydrogenase inhibitor
0,153  0,055  Cyclooxygenase 1 inhibitor
0,146  0,049  Proteasome inhibitor
0,123  0,026  Antiviral (Rhinovirus)
0,104  0,007  Nitric oxide donor
0,211  0,115  Flavin-containing monooxygenase substrate
0,151  0,055  Psychosexual dysfunction treatment
0,115  0,019  Na+ K+ transporting ATPase inhibitor
0,151  0,057  Tubulin antagonist
0,124  0,030  Antispirochetal
0,162  0,072  Interleukin 6 antagonist
0,187  0,097  Cardiodepressant
0,094  0,004  Arginase inhibitor
0,098  0,010  SULT2A1 substrate
0,268  0,180  DNA directed DNA polymerase inhibitor
0,132  0,045  MAO B inhibitor
0,166  0,078  Dual specificity phosphatase inhibitor
0,126  0,039  Dementia treatment
0,090  0,003  Sodium/glucose cotransporter inhibitor
0,138  0,051  Growth stimulant
0,101  0,015  Neuraminidase inhibitor
0,125  0,040  Chronic obstructive bronchitis treatment
0,130  0,045  Choleretic
0,113  0,029  Interleukin 5 antagonist
0,112  0,027  Opioid kappa receptor antagonist
0,113  0,028  Telomerase inhibitor
0,112  0,028  Phosphofructokinase-1 inhibitor
0,114  0,031  Phosphodiesterase 6D inhibitor
0,188  0,105  Antiviral (HIV)
0,120  0,039  Vascular dementia treatment
0,157  0,077  Uterine stimulant
0,164  0,085  Dual specificity phosphatase 3 inhibitor
0,095  0,016  Alpha tubulin antagonist
0,133  0,055  Beta amyloid protein antagonist
0,080  0,003  Sodium/glucose cotransporter 1 inhibitor
0,101  0,024  HIV-1 integrase inhibitor
0,140  0,065  Farnesoid X receptor antagonist
0,096  0,020  Anticholelithogenic
0,116  0,041  Prolactin inhibitor
0,083  0,009  Squalene epoxidase inhibitor
0,110  0,039  Triose-phosphate isomerase inhibitor
0,090  0,020  Antidote, heavy metal
0,159  0,089  Phospholipase C inhibitor
0,216  0,146  Immunomodulator
0,148  0,079  Aldose reductase substrate
0,203  0,134  Transcription factor STAT inhibitor
0,089  0,020  Neuraminidase (influenza) inhibitor
0,127  0,059  DNA repair enzyme inhibitor
0,144  0,076  Antidiabetic (type 1)
0,097  0,030  Histone deacetylase stimulant
0,097  0,030  Histone deacetylase SIRT1 stimulant
0,075  0,008  Cholesterol esterase inhibitor
0,101  0,034  Antibiotic
0,119  0,053  MAO A inhibitor
0,067  0,004  Estrogen-related receptor beta antagonist
0,067  0,004  Cholesterol absorption inhibitor
0,089  0,026  Antitreponemal
0,140  0,079  Cyclooxygenase inhibitor
0,088  0,028  MAP kinase kinase 7 inhibitor
0,087  0,028  Leukotriene antagonist
0,064  0,005  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,213  0,154  Cholesterol antagonist
0,154  0,094  Myocardial ischemia treatment
0,107  0,048  HIV-1 integrase (Overall Integration) inhibitor
0,103  0,045  Thioredoxin inhibitor
0,090  0,033  Cyclin B3 inhibitor
0,153  0,098  Amyloid beta precursor protein antagonist
0,123  0,069  Coagulant
0,078  0,023  Transcription factor AP-1 inhibitor
0,079  0,025  Carbonic anhydrase XII inhibitor
0,142  0,089  Hexokinase inhibitor
0,058  0,005  ATP citrate lysase inhibitor
0,101  0,049  ABCA1 expression enhancer
0,159  0,107  Pyruvate kinase inhibitor
0,139  0,087  MAP kinase kinase 4 inhibitor
0,067  0,016  Carbonic anhydrase IV inhibitor
0,125  0,073  Antihyperlipoproteinemic
0,059  0,008  Glucose-6-phosphate dehydrogenase inhibitor
0,133  0,082  Cell wall synthesis inhibitor
0,117  0,066  Transcription factor STAT6 inhibitor
0,112  0,064  Skin irritative effect
0,068  0,020  Antibiotic Glycopeptide-like
0,150  0,102  Neurotensin receptor agonist
0,069  0,024  Ca(v)3.2 blocker
0,096  0,051  Opioid antagonist
0,072  0,028  Protein kinase C eta inhibitor
0,129  0,086  Antineoplastic (carcinoma)
0,124  0,082  Bone formation stimulant
0,104  0,062  Adenylate kinase inhibitor
0,072  0,030  Antimycoplasmal
0,152  0,111  Antineoplastic (bone cancer)
0,087  0,046  Estrogen-related receptor beta agonist
0,078  0,037  Opioid delta receptor antagonist
0,063  0,023  Phosphorylase inhibitor
0,075  0,035  Glutamate (mGluR7) antagonist
0,087  0,047  Thioredoxin reductase inhibitor
0,059  0,019  Macrophage elastase inhibitor
0,115  0,076  Antifungal (Pneumocystis)
0,115  0,076  Antiviral (Hepatitis B)
0,081  0,043  Glutamate decarboxylase inhibitor
0,104  0,066  GST T1-1 substrate
0,079  0,040  Glycine receptor agonist
0,120  0,082  Antibacterial (Helicobacter pylori)
0,091  0,055  Antidote, mercury
0,117  0,081  Toll-Like receptor 2 antagonist
0,104  0,069  Antihelmintic (Fasciola)
0,220  0,185  Calcium channel activator
0,097  0,063  Sphingomyelinase inhibitor
0,087  0,053  Myeloperoxidase inhibitor
0,084  0,050  Ca(v)3.1 blocker
0,088  0,054  Protein kinase A inhibitor
0,054  0,022  Opioid kappa receptor agonist
0,244  0,212  Calcium channel L-type activator
0,072  0,040  Glucagon-like peptide 1 agonist
0,055  0,023  Glucose-6-phosphate isomerase inhibitor
0,058  0,026  Glucose-6-phosphate translocase inhibitor
0,208  0,176  Interleukin 2 agonist
0,043  0,012  Tubulin agonist
0,078  0,047  Glutamate dehydrogenase inhibitor
0,135  0,104  Heat shock protein 90 alpha antagonist
0,042  0,013  Nucleoside transporters inhibitor
0,046  0,018  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,061  0,033  Lipocortins synthesis agonist
0,064  0,036  Androgen agonist
0,114  0,087  Cyclooxygenase 2 inhibitor
0,050  0,024  Neuraminidase (Influenza A) inhibitor
0,149  0,122  Antimitotic
0,190  0,164  Gastrin inhibitor
0,119  0,094  Hair growth stimulant
0,057  0,033  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,074  0,051  CDC25A inhibitor
0,144  0,121  Anesthetic general
0,113  0,090  Contraceptive
0,069  0,047  Opioid mu receptor antagonist
0,049  0,029  Microtubule stabilization
0,043  0,024  Dopamine D5 agonist
0,050  0,032  Topoisomerase II beta inhibitor
0,156  0,138  Antineoplastic (lymphocytic leukemia)
0,054  0,037  Leukotriene B4 antagonist
0,066  0,049  Glutamate (mGluR6) antagonist
0,080  0,064  Antiviral (Trachoma)
0,151  0,135  Aryl hydrocarbon receptor agonist
0,055  0,040  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,059  0,044  Purinergic P2X1 antagonist
0,022  0,008  Antibiotic Anthracycline-like
0,056  0,042  Beta tubulin antagonist
0,085  0,073  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,093  0,081  DNA intercalator
0,180  0,168  Antineoplastic (bladder cancer)
0,071  0,060  Analgesic, opioid
0,137  0,126  ATPase inhibitor
0,057  0,046  Carbamoyl phosphate synthetase inhibitor
0,024  0,014  Prostaglandin F2 alpha agonist
0,178  0,168  Transcription factor STAT3 inhibitor
0,036  0,026  Antibiotic Aminoglycoside-like
0,136  0,128  Lipocortins synthesis antagonist
0,025  0,016  Protein 30S ribosomal subunit inhibitor
0,044  0,035  Opioid mu receptor agonist
0,054  0,046  Leukotriene C antagonist
0,082  0,074  Aminoacyl-tRNA synthetase inhibitor
0,055  0,049  Sphingosine kinase inhibitor
0,015  0,011  Antibiotic Tetracycline-like
0,047  0,043  Opioid agonist
0,032  0,029  HMG CoA reductase inhibitor
0,079  0,075  Antineoplastic, alkylator
0,069  0,065  Phosphodiesterase VI inhibitor
0,064  0,061  MDM2 inhibitor
0,030  0,028  Catechol O-methyltransferase inhibitor
0,090  0,089  Endometrios treatment
0,072  0,071  Glycine receptor antagonist
0,085  0,084  Interleukin 12 antagonist
0,039  0,038  DNA gyrase subunit A inhibitor

